Navigation Sciences

  • ABOUT
  • NaviSci SYSTEM
  • MARKETS
  • TEAM
  • NEWS
  • CONTACT

Real-Time Margin Measurement for Precision Cancer Surgery

Receive Newsletter

Home

Real-Time Margin Measurement for Precision Cancer Surgery

Real-Time Margin Measurement

for Precision Cancer Surgery

Addressing Unmet Needs in Soft Tissue Surgery

Navigation Sciences is developing the NaviSci™ system to address the growing need to locate and remove lung and other soft tissue cancers.

Real-time GPS Navigation

Real-time GPS
Navigation

Minimally Invasive

Precise Margin
Control

icon-minimally-invasive

Minimally
Invasive

The NaviSci System, which recently completed a clinical feasibility trial, has great potential to:

  • Reduce early-stage cancer recurrence risk
  • Conserve lung function
  • Improve surgical workflow
  • Shorten hospital length of stay

NaviSci’s first application is in early-stage lung cancer, where there are more than 76,000 new cases each year in the U.S.; the number is growing annually due to increasing adoption of CT x-ray screening.

Overall, there are approximately 450,000 soft tissue cancer diagnoses annually in the U.S. where NaviSci has potential application.

Addressable U.S. market opportunity Infographic

Recent News

Navigation updates in Q4 2022 newsletter

02/23 | 

Navigation updates in Q4 2022 newsletter Read more

Navigation updates in Q3 2022 newsletter

11/22 | 

Navigation updates in Q3 2022 newsletter Read more

Navigation updates in Q2 2022 newsletter

07/22 | 

Navigation updates in Q2 2022 newsletter Read more

Navigation updates in Q1 2022 newsletter

05/22 | 

Navigation updates in Q1 2022 newsletter Read more

Navigation Sciences presents at 2022 LSI Emerging Medtech Summit

05/22 | 

Navigation Sciences presents at 2022 LSI Emerging Medtech Summit Read more

NaviSci Q/4 2021 Year in Review | Progress updates in the development of our NaviSci™ Intelligent Surgical System for the localization and removal of early-stage lung tumors

01/22 | 

NaviSci Q/4 2021 Year in Review | Progress updates in the development of our NaviSci™ Intelligent Surgical System for the localization and removal of early-stage lung tumors Read more

Download Navigation Sciences Executive Summary

NaviSci is based on technology developed by the company’s co-founders, leaders in thoracic surgery and advanced surgical navigation technology, Raphael Bueno, M.D., Chief, Thoracic Surgery, and Jayender Jagadeesan, Ph.D., Associate Professor of Radiology both at Brigham & Women’s Hospital and Harvard Medical School. View our leadership team

Info@navigationsci.com
Brookline, MA

  • ABOUT
  • NaviSci SYSTEM
  • MARKETS
  • TEAM
  • NEWS
  • CONTACT

Copyright © 2023 Navigation Sciences, Inc. Navigation Sciences™, iVATS™, NaviSci™, NaviSci EndoMarker™, and J-Bar™ are Trademarks of Navigation Sciences, Inc. All rights reserved. U.S. and Foreign patents pending.
Caution – Investigational Device, Limited by Federal Law to Investigational Use. This device has not been cleared by the FDA and is Not Available for Sale in the United States.

  • ABOUT
  • NaviSci SYSTEM
  • MARKETS
  • TEAM
  • NEWS
  • CONTACT